Login
- Title:
Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?
- Document type:
- Journal Article
- Author(s):
- Rauscher, Isabel; Fendler, Wolfgang P; Hope, Thomas A; Quon, Andrew; Nekolla, Stephan G; Calais, Jeremie; Richter, Antonia; Haller, Bernhard; Herrmann, Ken; Weber, Wolfgang A; Czernin, Johannes; Eiber, Matthias
- Abstract:
- Our purpose was to define a clinically useful lower limit of injected dose for 68Ga-prostate-specific membrane antigen (PSMA)-11 PET/CT imaging of prostate cancer. Methods:68Ga-PSMA-11 PET/CT was performed on 11 patients. PET was acquired in list mode and reconstructed using a 3-min full acquisition, a 2-min acquisition, and a 1-min acquisition to generate images obtained with three thirds (standard dose), two thirds (low dose), and one third (very low dose) of the injected dose, respectively. Overall image quality (5-point scale) was assessed, and the detectability of PSMA-positive lesions was determined by 3 readers and compared with the reference standard. Results: Image quality declined with decreasing dose (mean score of 4.1 ± 0.4 for the standard dose, 3.4 ± 0.7 for the low dose, and 1.9 ± 0.4 for the very low dose; all P < 0.05). Readers 1, 2, and 3 correctly identified the lesions (n = 21) at a rate of 100%, 100%, and 95% with the standard dose; 95%, 81%, and 90% with the low dose; and 71%, 76%, and 59% with the very low dose, respectively. Conclusion:68Ga-PSMA-11 dose reduction is not feasible without a negative impact on image quality and lesion detectability.
- Journal title abbreviation:
- J Nucl Med
- Year:
- 2020
- Journal volume:
- 61
- Journal issue:
- 2
- Pages contribution:
- 189-193
- Fulltext / DOI:
- doi:10.2967/jnumed.119.227207
- Pubmed ID:
- http://view.ncbi.nlm.nih.gov/pubmed/31324710
- Print-ISSN:
- 0161-5505
- TUM Institution:
- Institut für Medizinische Statistik und Epidemiologie; Klinik und Poliklinik für Nuklearmedizin
BibTeX